Molecular predictors of outcome in early non-squamous non-small cell lung cancer

Key Points

• The study aims to evaluate molecular predictors of outcomes in early non-squamous non-small cell lung cancer (NSCLC).
• Utilized a 50-gene panel for next-generation sequencing in resected lung cancers
• Examined the incidence of driver mutations in early NSCLC
• Analyzed the prognostic significance of identified alterations
• Identified key driver mutations that influence clinical outcomes
• Demonstrated the importance of molecular testing in treatment planning
• Outlined the prevalence and implications of findings for future NSCLC management